Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 459 (TSXV: $SUGR.V) (TSX: $AVCN.TO) (CSE: $THC.C) (CSE: $CHV.C) (CSE: $TTT.C)
Delta, Kelowna, BC, August 24, 2020 (Investorideas.com Newswire)
www.Investorideas.com, a global news source covering leading sectors including
marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
Today’s podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.
In today’s podcast we look at a few public and private company announcements.
Sugarbud Craft Growers Corp. (TSXV: SUGR) announced that it has received approval from Health Canada for its amended sales license permitting the sale of dried cannabis products. Sugarbud is now able to directly sell its portfolio of exceptional craft cannabis products to all authorized provincial and territorial distributors/retailers as well as registered medical patients.
"Today's announcement represents yet another pivotal milestone for Sugarbud as we continue to scale up our commercial activities and build overall shareholder value for the Company," stated Sugarbud CEO, John Kondrosky. "Our amended Sales License now gives us the ability to take direct control of our own sales and marketing activities and further accelerate and expand the distribution of our core Craft Cannabis Dried Flower and Pre-Roll products into new target provinces - such as Alberta and British Columbia," continued Mr. Kondrosky.
The Company estimates that less than 30% of all active federally approved license holders possess a sales license permitting the sale of dried cannabis to authorized provincial and territorial distributors/retailers as well as registered medical patients. "Receipt of our amended Sales License is significant and was the result of a successful comprehensive inspection process. It is a testament to our day-to-day operational readiness and unwavering commitment to compliance as much as it is to the hard work, dedication and passion that our employees continue to demonstrate each and every day," concluded Mr. Kondrosky.
Sugarbud products are currently available in the province of Saskatchewan under the terms and conditions of the previously announced licensing and distribution agreement with Agro-Greens Natural Products Ltd.
Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products announced that through its majority owned subsidiary, Santa Marta Golden Hemp S.A.S., the company has completed exports of CBG and CBD isolates into the United States, CBD isolate into Germany and the commencement of a pilot tracking system for the export of its active pharmaceutical ingredient products in partnership with TruTrace Technologies Inc. (CSE: TTT) (OTCQB: TTTSF). The Company also announced that the Colombian Ministry of Justice and Law has granted SMGH a commercial and industrial cultivation quota for 12,264 THC plants by.
The export and sale of the commercial lot of isolated CBG into the United States was completed in parallel with commercial export of isolated CBD into the United States, as well as a pilot export for R&D purposes of CBD into Germany. The cultivation, extraction and purification of these cannabinoids including the rare cannabinoid, CBG, were all completed through Avicanna's vertical integration at SMGH and validate the company's innovation and leadership in natural rare cannabinoid production. The products are part of the Aureus™ product portfolio that now includes feminized seeds and advanced formulations as well as CBD, CBG and THC API products.
"This is another massive accomplishment for our team in Colombia as we enter the largest market in the world for non-psychoactive cannabinoids with our proprietary CBG offering. As the cannabinoid-derived products sector continues to evolve, our Aureus branded portfolio continues to advance in order to cater to the needs of our cosmetics and pharmaceutical partners, which require an innovative, credible, thoroughly-tested, organic, sustainable and economical source of input materials. Additionally, with the support of TruTrace, the Aureus products will be provided with traceability and trackability all the way back to the seed through a secured blockchain system." - Aras Azadian, Chief Executive Officer of Avicanna.
The Colombian Ministry of Justice and Law granted SMGH a supplementary cultivation quota to cultivate 12,264 psychoactive cannabis plants. 11,587 plants will be destined to produce dry flower which will then be used to manufacture psychoactive derivatives for commercial production for export. The remaining 677 plants will be utilized for psychoactive derivatives for the purposes of research and development and pilot production of Avicanna's RHO Phyto™ branded products in Colombia.
Lucas Nosiglia, President of Avicanna LATAM commented: "This achievement took years of characterization, evaluation and planning which will finally allow Avicanna to produce our THC products and export THC derivatives to our international partners. As one of the only companies permitted to produce THC commercially for the global market, we can focus on less competitive and high margin products."
THC BioMed announced that it has received notice from the U.S. Patent and Trademark Office, that it has allowed the patent application for THC's Clone Shipper Constant Illuminated, Tamper-Resistant Plant Container. This is a successful end to the patent application process. The next step will be the Issue Notification Letter to come from the USPTO, which THC expects to receive approximately 3 weeks prior to the official issuance date of the patent.
As noted in the title, this container provides the plant inside it with a constant source of light and helps plants do very well during shipping. The container is also tamper-resistant, which is important for shipping plants such as cannabis clones.
THC has also been focused on product development and sales for "Cannabis 2.0," with edibles and beverages. It has submitted the following new products to Health Canada for the 60-day notice period for new products:
THC BioMed's latest product, THC Kiss Gummies, are tasty gummy candies containing 2.5 mg of THC each. They will come with 4 in a package (10 mg.) The cannabis extract used is from the same proprietary extraction system as that used in THC Kiss beverage shot.
THC is also pleased to announce that a new product, Kiss Water, has been submitted to Health Canada. THC Kiss Water is a refreshing beverage with a slight herbal taste. Each 220 ml beverage contains 3 mg of THC.
THC chocolate has been formulated with the same cannabis extract used is from the same proprietary extraction system as that used in THC Kiss beverage shot and THC Kiss Gummies. The extract is designed to be fast acting and uplifting and to provide a realistic and great-tasting alternative to smoking cannabis.
Canada House Wellness Group Inc. (CSE: CHV) announced today that its wholly owned subsidiary, Abba Medix Corp., has received its amended sales license from Health Canada allowing for the sale of cannabis oil, concentrate, topical and edible products produced from its facility in Pickering, Ontario.
The Company also announced that Abba has entered into an agreement with Organic Extraction Technologies and is currently employing equipment and services sourced from OET to produce solventless cannabis rosin at its Pickering, Ontario facility.
This license amendment allows the Company to further expand its existing product offerings to the medical and recreational consumer markets with internally produced oil, concentrate, extract, topical and edible products. Abba is currently generating full-spectrum concentrates and will continue to work closely with Canada House's wholly owned subsidiary, Canada House Clinics ("CHC"), to expand its portfolio of products to best manage the complex physical and psychological conditions of its medical patient base.
"Receiving our Cannabis 2.0 sales license to allow for the sale of higher margin, internally produced products represents another key milestone on Canada House's path to profitability," said Chris Churchill-Smith, Canada House CEO. "Cannabis oil, rosin, and edibles are in high demand, and we've been developing formulations to address the health and wellness needs specifically as it relates to our Veteran patient base. This license amendment will allow Abba to capture an even greater share of the over $27M per year of medical products purchased by CHC's patients."
"It is a pleasure to work with Abba's terrific team while implementing our technology in their top-notch facility," commented Lindsay Labelle, CEO of Organic Extraction Technologies. "Solventless extraction without chemicals or additives only works with high quality cannabis. Our solventless products will allow us to showcase some of the best flower and trim in the industry. We are excited to bring the great genetics grown by Abba and its partners to market in new full-spectrum formats."
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.
Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Download our Mobile App for iPhone and Android
Join our Investor Club https://www.investorideas.com/membership/
800 665 0411